Multiple Myeloma
The latest news about Multiple Myeloma: headlines, AI summaries and the full story from every source.
- AbbVie Submits FDA Biologics License Application for Etentamig in Multiple Myeloma
- CellsBin Receives National Cancer Institute Award for Multiple Myeloma Blood Test Development
- Pfizer Announces Successful Late-Stage Trial for Multiple Myeloma Drug Elrexfio
- Adaptive Biotechnologies' clonoSEQ Named in Updated NCCN Guidelines for Multiple Myeloma
- AbbVie Reports Strong Phase 3 Results for Myeloma Treatment Etentamig
- Johnson & Johnson's Multiple Myeloma Drugs Show Improved Cancer-Free Survival
- FDA Accepts Bristol Myers' NDA for Mezigdomide Combo in Multiple Myeloma